Long-term follow-up data from the phase III MURANO trial showed sustained progression-free survival with fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan MURANO and...
Results presented at Foundation for Angelman Syndrome Therapeutics (FAST) Global Summit Additional data, including EEG findings, support prior initial indications...
- Beta thalassemia: All seven patients were transfusion independent with 3 to 18 months of follow-up after CTX001 infusion -...
First Reported Allogeneic CAR T Data in Multiple Myeloma Highlights Initial Safety and Efficacy in Heavily Pretreated, Refractory PatientsIn the...
Data support novel approach to develop and manufacture a best-in-class, durable medicine for people living with hemoglobinopathies IND filing for...
Lead immuno-oncology development candidate NTLA-5001 shows high anti-tumor activity as promising cancer treatment in proof-of-concept mouse models of acute leukemiasProprietary...
– Evidence of biologic activity observed in each dose-escalation cohort treated to date – – Clinical activity includes one CR...
CAMBRIDGE, Mass., Dec. 05, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the...
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a...
Dr. Jerry Chidester, or “Dr. Chiddy,” is a board-certified plastic and reconstructive surgeon who also specializes in hand surgery A...
● CommonHealth, a free service run by a nonprofit, has connected to 230 health systems in the United States, allowing...
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, ON / ACCESSWIRE / December...
Previous news segment has appeared on dozens of media stations nationwide CHARLOTTESVILLE, VA / ACCESSWIRE / December 4, 2020 /...
REDWOOD CITY, CA / ACCESSWIRE / December 4, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
TORONTO, ON / ACCESSWIRE / December 4, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital"...
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / December 4, 2020 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company...
The Sixth Tranche Accounts Receivable has a gross value of $3,810,587.04, representing customer billings over a 51-day period SAN FRANCISCO,...
Care team reviewing histopathology slides Pathologist reviewing histopathology slides Pathologist reviewing histopathology slides on 2 screens December 4, 2020 Latest...
NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device...
NEW YORK and PETACH TIKVA, Israel, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) (the “Company” or...